Live Status Check

NCT04064359 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 6:28 AM UTC

NCT04064359 Status Summary

NCT NumberNCT04064359
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment200 participants
Active Locations10 sites in the US
SponsorOxford BioTherapeutics Ltd
Last Updated on CT.govSeptember 16, 2025 (Sep 16, 2025)

About NCT04064359 Enrollment Status

As of July 13, 2026: Clinical trial NCT04064359 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 10 locations across the United States. The study is sponsored by Oxford BioTherapeutics Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT04064359

Is NCT04064359 still recruiting?

Yes, NCT04064359 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT04064359 recruiting?

This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT04064359?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT04064359 status last updated?

The official ClinicalTrials.gov record for NCT04064359 was last updated Sep 16, 2025 (September 16, 2025). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial